Hematology NewsOTX015 dose for lymphoma narrowed in phase 1 studyApril 10, 2016Indolent LymphomaAggressive LymphomasMultiple MyelomaLymphoma & Plasma Cell DisordersRare Diseases
Hematology NewsTemsirolimus results in good but short-duration responses in primary CNS lymphomaMarch 14, 2016Aggressive LymphomasNeuro-oncologyCNS/Brain CancerLymphoma & Plasma Cell Disorders
Hematology NewsPregnancy did not increase Hodgkin lymphoma relapse rateDecember 14, 2015Aggressive LymphomasLymphoma & Plasma Cell DisordersPatient & Survivor CareHodgkin Lymphoma
Hematology NewsExpert panel issues guidelines for treatment of hematologic cancers in pregnancyDecember 1, 2015CMLLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersAggressive LymphomasAMLIndolent Lymphoma
Hematology NewsMedical Roundtable: Pediatric Non-Hodgkin Lymphoma (NHL) Classification Guidelines - International Pediatric NHL Staging System (IPNHLSS)November 25, 2015Aggressive LymphomasHodgkin Lymphoma
Hematology NewsLupus and diffuse large B-cell lymphoma share genetic riskNovember 9, 2015Aggressive LymphomasPreventive CareB Cell Lymphoma
Hematology NewsMedical Roundtable: Hodgkin Lymphoma - Discussing Recent Evidence & Practice OptionsOctober 19, 2015Indolent LymphomaAggressive LymphomasHodgkin Lymphoma
Hematology NewsRoutine imaging for diffuse large B-cell lymphoma offers no survival benefitOctober 5, 2015Lymphoma & Plasma Cell DisordersAggressive LymphomasB Cell Lymphoma
Hematology NewsSecondary CNS lymphoma regimen linked to 41% survival at 5 yearsAugust 23, 2015Aggressive LymphomasLymphoma & Plasma Cell Disorders
Hematology NewsLymph2Cx assay identifies outcomes in DLBCLAugust 8, 2015Lymphoma & Plasma Cell DisordersAggressive Lymphomas
Hematology NewsLess toxic chemo for HIV-positive Burkitt lymphomaJuly 24, 2015Aggressive LymphomasLymphoma & Plasma Cell Disorders
Hematology NewsEarly follicular lymphoma progression signals poor outcomesJuly 24, 2015Aggressive LymphomasLymphoma & Plasma Cell DisordersFollicular Lymphoma
Oncology PracticeGuideline updated on hematopoietic colony-stimulating factorsJuly 14, 2015Patient & Survivor CareAggressive LymphomasCellular Therapy
Hematology NewsCUDC-907 passes early hurdle in heavily pretreated lymphoma, myelomaJuly 6, 2015Lymphoma & Plasma Cell DisordersAggressive LymphomasFollicular Lymphoma
Oncology PracticeABVD and Stanford V similar for bulky mediastinal Hodgkin’s lymphomaApril 20, 2015Lymphoma & Plasma Cell DisordersAggressive LymphomasHodgkin Lymphoma
